fluciclovine-f-18 and Cystadenoma--Serous

fluciclovine-f-18 has been researched along with Cystadenoma--Serous* in 1 studies

Other Studies

1 other study(ies) available for fluciclovine-f-18 and Cystadenoma--Serous

Article	Year
Incidental Serous Cystadenoma Presenting as a Photopenic Pancreatic Defect on 18F-Fluciclovine PET/CT. Clinical nuclear medicine, 2021, Dec-01, Volume: 46, Issue:12 18F-fluciclovine (Axumin) PET/CT has been widely used for the evaluation of biochemically recurrent prostate cancer following prior treatment. While lymph node and visceral organ metastases typically show increased radiotracer uptake, altered patterns of normal physiologic activity may also provide insight into other disease processes. We present a case of an incidental pancreatic head mass presenting as a photopenic defect on a staging 18F-fluciclovine PET/CT, which was subsequently confirmed to be a benign serous cystadenoma using multisequence MRI. Topics: Carboxylic Acids; Cyclobutanes; Cystadenoma, Serous; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms	2021

Article

Year

Incidental Serous Cystadenoma Presenting as a Photopenic Pancreatic Defect on 18F-Fluciclovine PET/CT.

Clinical nuclear medicine, 2021, Dec-01, Volume: 46, Issue:12

18F-fluciclovine (Axumin) PET/CT has been widely used for the evaluation of biochemically recurrent prostate cancer following prior treatment. While lymph node and visceral organ metastases typically show increased radiotracer uptake, altered patterns of normal physiologic activity may also provide insight into other disease processes. We present a case of an incidental pancreatic head mass presenting as a photopenic defect on a staging 18F-fluciclovine PET/CT, which was subsequently confirmed to be a benign serous cystadenoma using multisequence MRI.

Topics: Carboxylic Acids; Cyclobutanes; Cystadenoma, Serous; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms

2021